{"id":"https://openalex.org/W4379648564","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.3284","title":"AB0445 CHARACTERISTICS OF FIRST-LINE UPADACITINIB INITIATORS AND FACTORS CONTRIBUTING TO PRESCRIBING UPADACITINIB AS FIRST-LINE B/TSDMARD","display_name":"AB0445 CHARACTERISTICS OF FIRST-LINE UPADACITINIB INITIATORS AND FACTORS CONTRIBUTING TO PRESCRIBING UPADACITINIB AS FIRST-LINE B/TSDMARD","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379648564","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.3284"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2023-eular.3284","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.3284","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2023-eular.3284","pdf_url":"https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1412.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1412.1.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044834399","display_name":"Whitney S. Krueger","orcid":"https://orcid.org/0000-0003-1868-4300","observed_orcids":["https://orcid.org/0000-0003-1868-4300"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Krueger","raw_affiliation_strings":["AbbVie Inc, n/a, North Chicago, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, n/a, North Chicago, United States of America","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079841694","display_name":"Leslie R. Harrold","orcid":"https://orcid.org/0000-0002-0170-2747","observed_orcids":["https://orcid.org/0000-0002-0170-2747"]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Harrold","raw_affiliation_strings":["University of Massachusetts, Medical School, Worcester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Massachusetts, Medical School, Worcester, United States of America","institution_ids":["https://openalex.org/I166722992"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Sima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Sima","raw_affiliation_strings":["CorEvitas, n/a, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CorEvitas, n/a, Waltham, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048801906","display_name":"Thomas Eckmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Eckmann","raw_affiliation_strings":["CorEvitas, n/a, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CorEvitas, n/a, Waltham, United States of America","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029740944","display_name":"Ryan D. Kilpatrick","orcid":"https://orcid.org/0000-0003-1388-3669","observed_orcids":["https://orcid.org/0000-0003-1388-3669"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Kilpatrick","raw_affiliation_strings":["AbbVie Inc, n/a, North Chicago, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, n/a, North Chicago, United States of America","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":null,"first_page":"1412","last_page":"1412"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/upadacitinib","display_name":"upadacitinib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9470000267028809},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.7689999938011169},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.7250000238418579},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.4490000009536743},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.3149999976158142},{"id":"https://openalex.org/keywords/prescribing-factors","display_name":"prescribing factors","score":0.35600000619888306},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.328000009059906},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.30399999022483826},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7139999866485596},{"id":"https://openalex.org/keywords/subcutaneous-nodules","display_name":"subcutaneous nodules","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8032342195510864},{"id":"https://openalex.org/C2993493390","wikidata":"https://www.wikidata.org/wiki/Q5453208","display_name":"First line","level":2,"score":0.5195717811584473},{"id":"https://openalex.org/C198352243","wikidata":"https://www.wikidata.org/wiki/Q37105","display_name":"Line (geometry)","level":2,"score":0.4798521399497986},{"id":"https://openalex.org/C3019258254","wikidata":"https://www.wikidata.org/wiki/Q1423317","display_name":"Second line","level":3,"score":0.42660826444625854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1859288513660431},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2023-eular.3284","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.3284","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2023-eular.3284","pdf_url":"https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1412.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2023-eular.3284","doi":"https://doi.org/10.1136/annrheumdis-2023-eular.3284","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2023-eular.3284","pdf_url":"https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1412.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4379648564.pdf","grobid_xml":"https://content.openalex.org/works/W4379648564.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4401404175","https://openalex.org/W4366831749","https://openalex.org/W4399706402","https://openalex.org/W2952182954","https://openalex.org/W4399706377","https://openalex.org/W4283704737","https://openalex.org/W2889911592","https://openalex.org/W3164166839","https://openalex.org/W4411410910","https://openalex.org/W4391749959"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2023-06-08T00:00:00"}